Cargando…
Stem cell-based therapy for α(1)-antitrypsin deficiency
Human induced pluripotent stem cells offer the possibility of generating unlimited quantities of cells for autologous transplantation. By correcting the genetic defect underlying Z-allele α(1)-antitrypsin deficiency, we recently provided the first proof of principle for application of human induced...
Autores principales: | Rashid, S Tamir, Lomas, David A |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3340548/ https://www.ncbi.nlm.nih.gov/pubmed/22340671 http://dx.doi.org/10.1186/scrt95 |
Ejemplares similares
-
Targeted gene correction of α(1)-antitrypsin deficiency in induced pluripotent stem cells
por: Yusa, Kosuke, et al.
Publicado: (2011) -
Alpha-1-Antitrypsin Deficiency, the Serpinopathies and Conformational Disease
por: Parmar, Jas S, et al.
Publicado: (2000) -
The effects of weekly augmentation therapy in patients with PiZZ α1-antitrypsin deficiency
por: Schmid, ST, et al.
Publicado: (2012) -
The structural basis for Z α(1)-antitrypsin polymerization in the liver
por: Faull, Sarah V., et al.
Publicado: (2020) -
Update on α(1)-antitrypsin deficiency
por: Ferrarotti, Ilaria, et al.
Publicado: (2018)